DANIEL MUSHER to HIV Infections
This is a "connection" page, showing publications DANIEL MUSHER has written about HIV Infections.
Connection Strength
0.679
-
The lack of therapeutic benefit of adding hydroxyurea to highly active antiretroviral therapy (HAART). J Acquir Immune Defic Syndr. 2002 Jul 01; 30(3):363-4.
Score: 0.088
-
Colonization by Streptococcus pneumoniae among human immunodeficiency virus-infected adults: prevalence of antibiotic resistance, impact of immunization, and characterization by polymerase chain reaction with BOX primers of isolates from persistent S. pneumoniae carriers. J Infect Dis. 1997 Mar; 175(3):590-7.
Score: 0.061
-
IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis. 1996 Jun; 173(6):1347-53.
Score: 0.058
-
Neurosyphilis in HIV-infected persons. N Engl J Med. 1994 Dec 01; 331(22):1516-7.
Score: 0.052
-
Life-threatening Pseudomonas aeruginosa infections in patients with human immunodeficiency virus infection. Clin Infect Dis. 1992 Feb; 14(2):403-11.
Score: 0.043
-
Ulceronodular syphilis (lues maligna praecox) in a person newly diagnosed with HIV infection. BMJ Case Rep. 2011 Jul 20; 2011.
Score: 0.041
-
Syphilis, neurosyphilis, penicillin, and AIDS. J Infect Dis. 1991 Jun; 163(6):1201-6.
Score: 0.041
-
Antibiotic-resistant pneumonia in a hemophiliac with AIDS. Hosp Pract (Off Ed). 1991 Jan 15; 26(1):81-2.
Score: 0.040
-
Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med. 1990 Dec 01; 113(11):872-81.
Score: 0.039
-
Syphilis. Pediatr Infect Dis J. 1990 Oct; 9(10):768-9.
Score: 0.039
-
The effect of HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary alveolar macrophages. Am J Med Sci. 1990 Mar; 299(3):158-63.
Score: 0.037
-
Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS. 2004 May; 15(5):328-32.
Score: 0.025
-
Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine. Clin Infect Dis. 2003 Aug 01; 37(3):438-47.
Score: 0.024
-
Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users. Vaccine. 2002 Nov 01; 20(31-32):3720-4.
Score: 0.022
-
Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis. 1996 Jan; 173(1):83-90.
Score: 0.014
-
The current spectrum of Staphylococcus aureus infection in a tertiary care hospital. Medicine (Baltimore). 1994 Jul; 73(4):186-208.
Score: 0.013
-
Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infection. J Infect Dis. 1993 Jul; 168(1):75-83.
Score: 0.012
-
Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med. 1992 Nov; 93(5):481-8.
Score: 0.011
-
Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis. 1992 Mar; 165(3):553-6.
Score: 0.011
-
Unusual manifestations of pneumococcal infection in human immunodeficiency virus-infected individuals: the past revisited. Clin Infect Dis. 1992 Jan; 14(1):192-9.
Score: 0.011